- Molecules
- 13
MedsAcross lists 13 molecules linked to Bladder cancer, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- CarboplatinPlatinum-based Drug6 presentations1 brandL01XA02
- GemcitabineNucleoside Metabolic Inhibitor13 presentations2 brandsL01BC05
- MitomycinOrphanAlkylating Drug7 presentations4 brands
- CisplatinPlatinum-based Drug5 presentations1 brandL01XA01
- EtoposideTopoisomerase Inhibitor8 presentations3 brandsL01CB01
- ThiotepaOrphanAlkylating Drug7 presentations2 brandsL01AC01
- BevacizumabOrphanVascular Endothelial Growth Factor Inhibitor13 presentations17 brandsL01FG01
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- AtezolizumabOrphanAntibodies2 presentations2 brandsL01FF05
- ValrubicinOrphan2 presentations1 brandL01DB09
- PembrolizumabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation1 brandL01FF02
- AvelumabOrphanAntibodies1 presentation2 brandsL01FF04
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Bladder cancer?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.